SEC Form 4 · accession 0001645627-17-000125
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 2, 2017
Accepted (ET)
Oct 5, 2017 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 2, 2017 | P | 2,000 | $0.059 | A | 23,652,189 | D | |
| Common Stock | Oct 2, 2017 | P | 3,000 | $0.059 | A | 23,655,189 | D | |
| Common Stock | Oct 2, 2017 | P | 2,000 | $0.059 | A | 23,657,189 | D | |
| Common Stock | Oct 2, 2017 | P | 3,000 | $0.059 | A | 23,660,189 | D | |
| Common Stock | Oct 2, 2017 | P | 2,000 | $0.059 | A | 23,662,189 | D | |
| Common Stock | Oct 2, 2017 | P | 2,000 | $0.0591 | A | 23,664,189 | D | |
| Common Stock | Oct 2, 2017 | P | 2,000 | $0.0591 | A | 23,666,189 | D | |
| Common Stock | Oct 2, 2017 | P | 2,000 | $0.0591 | A | 23,668,189 | D | |
| Common Stock | Oct 2, 2017 | P | 2,000 | $0.0695 | A | 23,670,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.0645 | A | 23,672,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.0679 | A | 23,674,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.069 | A | 23,676,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.069 | A | 23,678,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.071 | A | 23,680,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.0725 | A | 23,682,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.0724 | A | 23,684,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.0725 | A | 23,686,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.073 | A | 23,688,189 | D | |
| Common Stock | Oct 3, 2017 | P | 2,000 | $0.0715 | A | 23,690,189 | D |
Table II — derivative securities
No Table II lines on this filing.